Cargando…
PET/MRI for Staging the Axilla in Breast Cancer: Current Evidence and the Rationale for SNB vs. PET/MRI Trials
SIMPLE SUMMARY: PET/MRI is a relatively new, hybrid imaging tool that allows practitioners to obtain both a local and systemic staging in breast cancer patients in a single exam. To date, the available evidence is not sufficient to determine the role of PET/MRI in breast cancer management. The aims...
Autores principales: | Di Micco, Rosa, Santurro, Letizia, Gasparri, Maria Luisa, Zuber, Veronica, Cisternino, Giovanni, Baleri, Sara, Morgante, Manuela, Rotmensz, Nicole, Canevari, Carla, Gallivanone, Francesca, Scifo, Paola, Savi, Annarita, Magnani, Patrizia, Neri, Ilaria, Ferjani, Nadia, Venturini, Elena, Losio, Claudio, Sassi, Isabella, Bianchini, Giampaolo, Panizza, Pietro, Gianolli, Luigi, Gentilini, Oreste Davide |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8303241/ https://www.ncbi.nlm.nih.gov/pubmed/34298781 http://dx.doi.org/10.3390/cancers13143571 |
Ejemplares similares
-
Biomarkers from in vivo molecular imaging of breast cancer: pretreatment (18)F-FDG PET predicts patient prognosis, and pretreatment DWI-MR predicts response to neoadjuvant chemotherapy
por: Gallivanone, Francesca, et al.
Publicado: (2017) -
A Partial Volume Effect Correction Tailored for (18)F-FDG-PET Oncological Studies
por: Gallivanone, F., et al.
Publicado: (2013) -
Markerless motion tracking and correction for PET, MRI, and simultaneous PET/MRI
por: Slipsager, Jakob M., et al.
Publicado: (2019) -
MRI and PET/MRI in hematologic malignancies
por: Mayerhoefer, Marius E., et al.
Publicado: (2019) -
A Method for Manufacturing Oncological Phantoms for the Quantification of 18F-FDG PET and DW-MRI Studies
por: Gallivanone, Francesca, et al.
Publicado: (2017)